HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical use of a calcium antagonistic agent (nifedipine) in acute pulmonary edema.

Abstract
Nifedipine induces vascular smooth muscle relaxation through a calcium antagonistic action. The possibility of clinical use of the drug as a ventricular unloading agent has been explored in this study. In patients with hypertensive (seven cases), primary (seven cases) or rheumatic (aortic insufficiency five cases, mitral regurgitation five cases) cardiac disease, nifedipine, administered in a single sublingual dose (10 mg), relieved acute pulmonary edema. Circulatory variations from control were the following: decrease of systemic and pulmonary arterial pressures, and of vascular resistances, of pulmonary wedge pressure, of left ventricular diastolic and systolic dimensions (echocardiography); increase of cardiac and stroke index, of left ventricular mean rate of circumferential fiber shortening, of left and right mean pre-ejection delta P/delta t and mean rate of ejection; improvement of forward output in primary and rheumatic disease. Nifedipine benefits acute congestive heart failure by sustained fall of both preload and afterload and, possibly, by an enhanced contractility. It seems to have an appropriate indication in cases in which left ventricular afterload reduction is desirable.
AuthorsA Polese, C Fiorentini, M T Olivari, M D Guazzi
JournalThe American journal of medicine (Am J Med) Vol. 66 Issue 5 Pg. 825-30 (May 1979) ISSN: 0002-9343 [Print] United States
PMID443258 (Publication Type: Journal Article)
Chemical References
  • Pyridines
  • Nifedipine
  • Calcium
Topics
  • Adult
  • Aged
  • Blood Pressure (drug effects)
  • Calcium (antagonists & inhibitors)
  • Cardiomyopathies (complications)
  • Female
  • Humans
  • Hypertension (complications)
  • Male
  • Middle Aged
  • Muscle, Smooth (drug effects)
  • Myocardial Contraction (drug effects)
  • Nifedipine (therapeutic use)
  • Pulmonary Edema (drug therapy, etiology)
  • Pyridines (therapeutic use)
  • Rheumatic Heart Disease (complications)
  • Stroke Volume (drug effects)
  • Vascular Resistance (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: